Peculiarities of antibiotic-associated diarrhea development in children with acute respiratory infections

Sergii V Popov1, Oleksandr I Smyian1, Andrii N Loboda1

  • 1Sumy State University, Department of Pediatrics, Sumy, Ukraine

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|February 24, 2019
PubMed

Insights

Antibiotic-associated diarrhea (AAD) affects over half of children with acute respiratory infections (ARI). Key risk factors include limited breastfeeding, gastrointestinal issues, allergies, and parental health habits.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Gastroenterology

Background:

  • Acute respiratory infections (ARI) are a leading cause of childhood illness globally.
  • Antibiotic administration for ARI carries the risk of side effects, including antibiotic-associated diarrhea (AAD).

Purpose of the Study:

  • To determine the prevalence of AAD in children with ARI.
  • To identify factors influencing the development of AAD in this pediatric population.

Main Methods:

  • A study involving 75 children aged 1-12 years diagnosed with ARI and treated with antibiotics.
  • Analysis of children's medical history, parental health, and odds ratios (OR) to assess AAD risk factors.

Main Results:

  • Overall AAD incidence was 52%, highest (59.3%) in children under 3 years.
  • Amoxicillin treatment was associated with 92% of AAD cases.
  • Significant risk factors included breastfeeding <6 months (OR 7.65), preterm birth (OR 2.9), and parental factors like age >35 (OR 5.03) and smoking (OR 2.43).

Conclusions:

  • Breastfeeding duration, infant's gastrointestinal and allergic history are critical for AAD development.
  • Parental health, including gastrointestinal disorders, allergies, and smoking, significantly increases AAD risk in children treated for ARI.
Abstract

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
977
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
493
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
869
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
555